Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Nano-Adjuvant : New Ray of Hope against Anti-Microbial Resistance


Affiliations
1 Department of Microbiology, Institute of Post Graduate Medical Education & Research, (IPGMER), Kolkata, India
     

   Subscribe/Renew Journal


Nano-particles derived from heavy metal compounds with or without weak antimicrobial action, always express accentuated antimicrobial action in-vitro. Of these, nano silver particles (AgNPs) have been extensively studied, though limitedly used for infection control as topical applications on burn wound or surface ulcers only. Antimicrobial actions of ionic silver mediate through coagulation of some cell proteins, structural changes in cell wall and cell membrane, binding to bacterial DNA and interaction with thiol group proteins in cell and respiratory enzymes, resulting cell distortion and death. AgNPs are formed by physical transformation into energized smaller aggregations of silver molecules in presence of suitable reducing and stabilizing polymeric surfactants. Greater antibacterial effect of AgNPs are partly due to release of excess ionic silver inside cells but mostly due to closer interactions of charged tiny particles to cell surface, intercalation between DNA bases and destabilization of cell wall and ribosome. The "bonus antimicrobial effect" of AgNPs is expected to be resistance-proof by way of bacterial molecular adaptation. Universal synergism of AgNPs with conventional antibiotics is also expected due to its damaging effects of different target sites. By our in-vitro study this has been demonstrated and prompts us to test it as a sharp weapon against superbugs, which can restrain bacteria from resistant development. Thus nano-antibiotics may play very important supportive role to combat superbug.
User
Subscription Login to verify subscription
Notifications
Font Size

  • S Pal, YK Tak, JM Song. 2007. Dose the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle ? A study of the Gram-negative bacterium Escherichia coli. Appl. Environ. Microbiol. 73(6):1712-20.
  • A Mendez-Vilas. Science against microbial pathogens: Communicating current research and technological advances. Vol.1.Spain: Formatex Research Center; 2011:197-209.
  • V. Vadlapudi, D.S.V.G.K. Kaladhar, M. Behara, G.K. Naidu, B. Sujatha Review: Green Synthesis of Silver and Gold nanoparticles. International Journal of Chemical Studies.2013 NOV-DEC; 1(4) : 22.
  • J Jain, S Arora, JM Rajwade, P Omray, S Khandelwal, KM. Paknikar Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Molecular Pharmacology. 2009 Sep-Oct; 6 (5):1388.
  • I.S. Hwang, J.H. Hwang, H. Choi, K.J. Kim, D.G. Lee Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved. Journal of Medical Microbiology .2012Dec; 61:1719-1726.
  • A.J. Kora and L. Rastogi Enhancement of Antibacterial Activity of Capped Silver Nanoparticles in Combination with Antibiotics, on Model Gram-Negative and Gram-Positive Bacteria, Bioinorganic Chemistry and Applications. 2013;2013:1-7.
  • A.J. Huh, Y.J. Kwon “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. Journal of Controlled Release. 2011Jul;156:131-133.
  • S. Prabhu, E.K. Poulose, Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects [Internet]. 2012 October ; [ cited 2013 Dec19]. Available from: http://www.inl-journal.com/content/2/1/32
  • L.S. Garcia, H.D. Isenberg Clinical Microbiology Procedures Handbook.2nd ed. Update. Washington. DC. American Society for Microbiology;2007.
  • MA Ansari, AA Khan, SS Cameotra, MA. Alzohairy Anti-biofilm efficacy of silver nanoparticles against MRSA and MRSE isolated from wounds in a tertiary care hospital. Indian J Med Microbiol 2015; 33:101-9.
  • A Sotiriou Georgios, A. Pratsinis Sotiris Engineering nanosilver as an antibacterial, biosensor and bioimaging material. Curr Opin Chem Eng 2011;1(1):3-10. Doi:10.1016/j.coche.2011.07.001.

Abstract Views: 427

PDF Views: 3




  • Nano-Adjuvant : New Ray of Hope against Anti-Microbial Resistance

Abstract Views: 427  |  PDF Views: 3

Authors

Prasanta Kumar Maiti
Department of Microbiology, Institute of Post Graduate Medical Education & Research, (IPGMER), Kolkata, India

Abstract


Nano-particles derived from heavy metal compounds with or without weak antimicrobial action, always express accentuated antimicrobial action in-vitro. Of these, nano silver particles (AgNPs) have been extensively studied, though limitedly used for infection control as topical applications on burn wound or surface ulcers only. Antimicrobial actions of ionic silver mediate through coagulation of some cell proteins, structural changes in cell wall and cell membrane, binding to bacterial DNA and interaction with thiol group proteins in cell and respiratory enzymes, resulting cell distortion and death. AgNPs are formed by physical transformation into energized smaller aggregations of silver molecules in presence of suitable reducing and stabilizing polymeric surfactants. Greater antibacterial effect of AgNPs are partly due to release of excess ionic silver inside cells but mostly due to closer interactions of charged tiny particles to cell surface, intercalation between DNA bases and destabilization of cell wall and ribosome. The "bonus antimicrobial effect" of AgNPs is expected to be resistance-proof by way of bacterial molecular adaptation. Universal synergism of AgNPs with conventional antibiotics is also expected due to its damaging effects of different target sites. By our in-vitro study this has been demonstrated and prompts us to test it as a sharp weapon against superbugs, which can restrain bacteria from resistant development. Thus nano-antibiotics may play very important supportive role to combat superbug.

References





DOI: https://doi.org/10.24906/isc%2F2017%2Fv31%2Fi2%2F152005